Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide

Pediatric Blood and Cancer

Volumn 46, Issue 2, 2006, Pages 239-242

  Gottschling, Sven ^a   Schneider, G ^a   Meyer, S ^a   Reinhard, H ^a   Dill Mueller, D ^a   Graf, N ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Clophosphamide; Corticosteroids; Diffuse neonatal hemangiomatosis; Interferon; Liver hemangioma

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; MESNA; PREDNISOLONE; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ARTICLE; AVASCULAR NECROSIS; BENIGN TUMOR; BRAIN HEMANGIOMA; CANCER RISK; CARDIOMYOPATHY; CASE REPORT; CONSTIPATION; DEMYELINATING DISEASE; DIFFUSE NEONATAL HEMANGIOMATOSIS; DRUG COST; DRUG EFFICACY; FEMALE; FEVER; GRANULOCYTOPENIA; HEMANGIOMA; HEMANGIOMATOSIS; HEMORRHAGIC CYSTITIS; HUMAN; ILEUS; INFANT; LIVER HEMANGIOMA; LIVER TOXICITY; LUNG FIBROSIS; MALE; NEWBORN; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYNEUROPATHY; PRIORITY JOURNAL; SKIN HEMANGIOMA; SPASTICITY; TREATMENT OUTCOME; TUMOR REGRESSION; UROGENITAL TRACT DISEASE;

ADRENAL CORTEX HORMONES; ANGIOMATOSIS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HEART DISEASES; HEMANGIOMA; HUMANS; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 30444436295     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20522     Document Type: Article

References (25)

1. Enjolras O, Riche MC, Merland JJ, et al. Management of alarming hemangiomas in infancy: A review of 25 cases. Pediatrics 1990;85:491-498.
2. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-222.
3. Hurvitz SA, Hurvitz CH, Sloninsky L, et al. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000;22:527-532.
4. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: A twenty-seven-year experience. J Pediatr 1996;129:346-354.
5. Golitz LE, Rudikoff J, O'Meara OP. Diffuse neonatal hemangiomatosis. Pediatr Dermatol 1986;3:145-152.
6. O'Hagan AH, Irvine AD, Sands A, et al. Miliary neonatal hemangiomatosis with fulminant heart failure and cardiac septal hypertrophy in two infants. Pediatr Dermatol 2004;21:469-472.
7. Stratte EG, Tope WD, Johnson CL, et al. Multimodal management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol 1996;34:337-342.
8. Rotman M, John M, Stowe S, et al. Radiation treatment of pediatric hepatic hemangiomatosis and coexisting cardiac failure. N Engl J Med 1980;302:852.
9. Alkalay AL, Puri AR, Pomerance JJ, et al. Mesenchymal hamartoma of the liver responsive to cyclophosphamide therapy. Therapeutic approach. J Pediatr Surg 1985;20:125-128.
10. al-Rashid RA. Cyclophosphamide and radiation therapy in the treatment of hemangioendothelioma with disseminated intravascular clotting. Cancer 1971;27:364-368.
11. Burrows PE, Rosenberg HC, Chuang HS. Diffuse hepatic hemangiomas: Percutaneous transcatheter embolization with detachable silicone balloons. Radiology 1985;156:85-88.
12. Castro R, Meek R, Bean C, et al. Successful treatment of a giant cavernous hemangioma with oral cyclophosphamide (cytoxan) in an infant. Del Med J 1992;64:745-749.
13. deLorimier AA, Simpson EB, Baum RS, et al. Hepatic-artery ligation for hepatic hemangiomatosis. N Engl J Med 1967;277:333-337.
14. Enjolras O, Breviere GM, Roger G, et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004;11:99-107.
15. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-1463.
16. Hurvitz CH, Alkalay AL, Sloninsky L, et al. Cyclophosphamide therapy in life-threatening vascular tumors. J Pediatr 1986;109:360-363.
17. Hurvitz CH, Greenberg SH, Song CH, et al. Hemangiomatosis of the pleura with hemorrhage and disseminated intravascular coagulation. J Pediatr Surg 1982;17:73-75.
18. Manglani M, Chari G, Sharma U, et al. Successful treatment with cyclophosphamide in a large hepatic hemangioendothelioma. Indian Pediatr 1994;31:875-877.
19. Orchard PJ, Smith CM III, Woods WG, et al. Treatment of haemangioendotheliomas with alpha interferon. Lancet 1989;2:5 65-567.
20. Perez Payarols J, Pardo Masferrer J, Gomez Bellvert C. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995;333:69.
21. Schiavon G, Dal Pozzo A, Alessandrini H. Hepatic hemangioma in the neonate: Description of a case treated surgically with favorable outcome. Pediatr Med Chir 1982;4:571-573.
22. Stillman AE, Hansen RC, Hallinan V, et al. Diffuse neonatal hemangiomatosis with severe gastrointestinal involvement. Favorable response to steroid therapy. Clin Pediatr (Phila) 1983;22:589-591.
23. Young RS, Zalneraitis EL, Bauman ML. Disseminated neonatal hemangiomatosis: Successful hepatic resection with subsequent development of hydrocephalus. J Pediatr Surg 1981;16:752-753.
24. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-530.
25. Pizzo PA, Poplack DG, editors. Principles and practise of pediatric oncology. Philadelphia: J.B. Lippincott company; 1993. p 1092.